JP6419791B2 - 多成分分析の較正 - Google Patents

多成分分析の較正 Download PDF

Info

Publication number
JP6419791B2
JP6419791B2 JP2016517286A JP2016517286A JP6419791B2 JP 6419791 B2 JP6419791 B2 JP 6419791B2 JP 2016517286 A JP2016517286 A JP 2016517286A JP 2016517286 A JP2016517286 A JP 2016517286A JP 6419791 B2 JP6419791 B2 JP 6419791B2
Authority
JP
Japan
Prior art keywords
calibration
signal
components
sample
predetermined number
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
JP2016517286A
Other languages
English (en)
Japanese (ja)
Other versions
JP2016523359A5 (https=
JP2016523359A (ja
Inventor
クライダー ビルヘルム
クライダー ビルヘルム
クレーマー ハンス−ディーター
クレーマー ハンス−ディーター
スルカ ペーター
スルカ ペーター
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
F Hoffmann La Roche AG
Original Assignee
F Hoffmann La Roche AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by F Hoffmann La Roche AG filed Critical F Hoffmann La Roche AG
Publication of JP2016523359A publication Critical patent/JP2016523359A/ja
Publication of JP2016523359A5 publication Critical patent/JP2016523359A5/ja
Application granted granted Critical
Publication of JP6419791B2 publication Critical patent/JP6419791B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Images

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/5306—Improving reaction conditions, e.g. reduction of non-specific binding, promotion of specific binding
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N35/00—Automatic analysis not limited to methods or materials provided for in any single one of groups G01N1/00 - G01N33/00; Handling materials therefor
    • G01N35/00584—Control arrangements for automatic analysers
    • G01N35/00594—Quality control, including calibration or testing of components of the analyser
    • G01N35/00693—Calibration
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/5308—Immunoassay; Biospecific binding assay; Materials therefor for analytes not provided for elsewhere, e.g. nucleic acids, uric acid, worms, mites
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
    • G01N33/54313—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals the carrier being characterised by its particulate form
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N35/00—Automatic analysis not limited to methods or materials provided for in any single one of groups G01N1/00 - G01N33/00; Handling materials therefor
    • G01N35/00584—Control arrangements for automatic analysers
    • G01N35/00594—Quality control, including calibration or testing of components of the analyser
    • G01N35/00693—Calibration
    • G01N2035/00702—Curve-fitting; Parameter matching; Calibration constants
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N21/00—Investigating or analysing materials by the use of optical means, i.e. using sub-millimetre waves, infrared, visible or ultraviolet light
    • G01N21/17—Systems in which incident light is modified in accordance with the properties of the material investigated
    • G01N21/59—Transmissivity
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2201/00—Features of devices classified in G01N21/00
    • G01N2201/12—Circuits of general importance; Signal processing
    • G01N2201/127—Calibration; base line adjustment; drift compensation
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/46—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans from vertebrates
    • G01N2333/47—Assays involving proteins of known structure or function as defined in the subgroups
    • G01N2333/4701—Details
    • G01N2333/4737—C-reactive protein
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N27/00—Investigating or analysing materials by the use of electric, electrochemical, or magnetic means
    • G01N27/26—Investigating or analysing materials by the use of electric, electrochemical, or magnetic means by investigating electrochemical variables; by using electrolysis or electrophoresis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Biomedical Technology (AREA)
  • Analytical Chemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Physics & Mathematics (AREA)
  • Biotechnology (AREA)
  • Cell Biology (AREA)
  • Microbiology (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Quality & Reliability (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Automatic Analysis And Handling Materials Therefor (AREA)
  • Investigating Or Analysing Materials By The Use Of Chemical Reactions (AREA)
  • Investigating Or Analysing Materials By Optical Means (AREA)
  • Electrochemistry (AREA)
JP2016517286A 2013-06-07 2014-06-04 多成分分析の較正 Active JP6419791B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP13171044.4A EP2811300A1 (en) 2013-06-07 2013-06-07 Calibration for multi-component assays
EP13171044.4 2013-06-07
PCT/EP2014/061571 WO2014195355A1 (en) 2013-06-07 2014-06-04 Calibration for multi-component assays

Publications (3)

Publication Number Publication Date
JP2016523359A JP2016523359A (ja) 2016-08-08
JP2016523359A5 JP2016523359A5 (https=) 2018-05-24
JP6419791B2 true JP6419791B2 (ja) 2018-11-07

Family

ID=48578854

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2016517286A Active JP6419791B2 (ja) 2013-06-07 2014-06-04 多成分分析の較正

Country Status (7)

Country Link
US (1) US11378573B2 (https=)
EP (2) EP2811300A1 (https=)
JP (1) JP6419791B2 (https=)
CN (1) CN105637365B (https=)
CA (1) CA2904256C (https=)
ES (1) ES2768198T3 (https=)
WO (1) WO2014195355A1 (https=)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2900201C (en) 2014-08-25 2025-01-07 Bio-Rad Laboratories, Inc. VALUE ASSIGNMENT TO CUSTOMIZABLE QUALITY CONTROLS
KR102146434B1 (ko) 2015-12-17 2020-08-21 에이에스엠엘 네델란즈 비.브이. 측정을 향상시키기 위한 비대칭 서브 해상도 피처를 사용하는 리소그래피 공정의 광학적 메트롤로지
JP6805272B2 (ja) * 2016-06-15 2020-12-23 エフ．ホフマン−ラ ロシュ アーゲーＦ． Ｈｏｆｆｍａｎｎ−Ｌａ Ｒｏｃｈｅ Ａｋｔｉｅｎｇｅｓｅｌｌｓｃｈａｆｔ 改善されたｄダイマーアッセイ較正
WO2018099859A1 (en) 2016-12-02 2018-06-07 Roche Diagnostics Gmbh Failure state prediction for automated analyzers for analyzing a biological sample
US11209417B2 (en) * 2017-10-12 2021-12-28 Carrot, Inc. Breath sensor apparatus and methods of use
CN111239426B (zh) * 2018-11-29 2023-12-01 深圳市帝迈生物技术有限公司 样本分析仪及其自动校准的方法
GB2579810B (en) * 2018-12-14 2023-04-26 Aeirtec Ltd Assay Analysis
EP4289510A3 (en) 2018-12-28 2024-06-12 Beckman Coulter, Inc. Clinical analyzer automated system diagnostics
JP2020201174A (ja) * 2019-06-12 2020-12-17 国立研究開発法人物質・材料研究機構 スペクトル解析装置用の成分同定装置及びその方法、コンピュータプログラム
EP3757547B1 (en) 2019-06-28 2022-11-23 ABB Schweiz AG Turbidity calibration-correction apparatus and method for an automated calibration correction
EP4078652A1 (en) * 2019-12-17 2022-10-26 F. Hoffmann-La Roche AG Method for calibrating at least one mass spectrometry device
EP4078168B1 (en) 2019-12-17 2026-04-01 Roche Diagnostics GmbH Method for calibrating at least one analytic device with multiple repeated hardware components
CN114901139B (zh) 2019-12-31 2025-10-28 麦克内尔股份公司 呼吸传感器校准方法和装置
CN112462078A (zh) * 2020-11-16 2021-03-09 三诺生物传感股份有限公司 一种用于荧光免疫分析仪台间差校准的方法
CN112730203B (zh) * 2020-12-29 2023-06-16 深圳市科曼医疗设备有限公司 血球分析仪的光学系统、光学增益校准方法和存储介质
JP2024507652A (ja) * 2021-01-11 2024-02-21 メソ スケール テクノロジーズ エルエルシー アッセイシステムの較正システム及び方法
CN116413249A (zh) * 2021-12-31 2023-07-11 科美诊断技术股份有限公司 一种校准结果处理方法、系统及样本分析仪

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3645023B2 (ja) * 1996-01-09 2005-05-11 富士写真フイルム株式会社 試料分析方法、検量線の作成方法及びそれを用いる分析装置
EP0898169B1 (en) * 1997-08-11 2002-02-06 F. Hoffmann-La Roche Ag Microparticle enhanced light scattering assay and microparticle reagents therefor
CA2244326C (en) * 1997-08-11 2006-03-28 Shinichi Eda Microparticle enhanced light scattering agglutination assay and microparticle reagents therefor
US6277584B1 (en) * 1998-12-16 2001-08-21 Dade Behring Inc. Method for calibrating a chemical analyzer with improved accuracy at low signal levels
EP1702561B1 (en) * 2002-03-22 2011-05-04 Animas Technologies LLC Improving performance for an analyte monitoring device
JP4331073B2 (ja) * 2004-08-31 2009-09-16 デンカ生研株式会社 抗原の測定方法及びそのための試薬
JP2009063335A (ja) * 2007-09-05 2009-03-26 Fujifilm Corp 生理活性物質と被験物質との相互作用の測定方法
CN102216784B (zh) * 2008-11-17 2014-07-09 株式会社日立高新技术 自动分析装置
US8802446B2 (en) * 2008-12-04 2014-08-12 Sekisui Medical Co., Ltd. Method for measuring cystatin C in human body fluid

Also Published As

Publication number Publication date
US20160084861A1 (en) 2016-03-24
EP3004880A1 (en) 2016-04-13
ES2768198T3 (es) 2020-06-22
JP2016523359A (ja) 2016-08-08
US11378573B2 (en) 2022-07-05
CA2904256A1 (en) 2014-12-11
HK1220758A1 (zh) 2017-05-12
EP3004880B1 (en) 2019-11-20
CN105637365B (zh) 2018-04-24
CN105637365A (zh) 2016-06-01
CA2904256C (en) 2019-09-10
WO2014195355A1 (en) 2014-12-11
EP2811300A1 (en) 2014-12-10

Similar Documents

Publication Publication Date Title
JP6419791B2 (ja) 多成分分析の較正
JP6576914B2 (ja) 測光のための較正方法
Vashist et al. Bioanalytical requirements and regulatory guidelines for immunoassays
US10809258B2 (en) Method for the detection of the prozone effect of photometric assays
Dimeski Interference testing
Clarke et al. Challenges in implementing clinical liquid chromatography–tandem mass spectrometry methods–seeing the light at the end of the tunnel
Mondésert et al. A French multicenter analytical evaluation of the automated Lumipulse G sNfL blood assay (Fujirebio®) and its comparison to four other immunoassays for serum neurofilament light chain assessment in clinical settings
Fairman et al. Best practices in mAb and soluble target assay selection for quantitative modelling and qualitative interpretation
US9594088B2 (en) Multiple time windows with associated calibration curves for extending the range of an assay
Anaya-Cubero et al. Application of single molecule array (SIMOA) in cerebrospinal fluid
HK1220758B (en) Calibration for multi-component assays
Šegulja et al. Verification study of free light chains assays on reagent-optimized analysers
JPH06138129A (ja) マイクロプレートリーダー
JP5602027B2 (ja) 未来の性質を予測する方法
Ray Fit-for-purpose validation
Allison et al. B-083 Validation of Alzheimer’s Disease Markers in CSF
Mansfield et al. Biomarkers for pharmacogenetic and pharmacogenomic studies: Locking down analytical performance
HK1209487B (en) Immunoassay-based determination of in-solution binding kinetics
HK1221505B (en) Method for the detection of the prozone effect of photometric assays

Legal Events

Date Code Title Description
A529 Written submission of copy of amendment under article 34 pct

Free format text: JAPANESE INTERMEDIATE CODE: A529

Effective date: 20151016

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20170308

A977 Report on retrieval

Free format text: JAPANESE INTERMEDIATE CODE: A971007

Effective date: 20171227

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20180109

A524 Written submission of copy of amendment under article 19 pct

Free format text: JAPANESE INTERMEDIATE CODE: A524

Effective date: 20180404

TRDD Decision of grant or rejection written
A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

Effective date: 20180918

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20181010

R150 Certificate of patent or registration of utility model

Ref document number: 6419791

Country of ref document: JP

Free format text: JAPANESE INTERMEDIATE CODE: R150

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250